drugset / Trial / NCT00214786
Pancreatic Islet Cell Transplantation
Phase 1
Completed
4 enrolled
Baylor Research Institute
Baylor Health Care System · collabUniversity of Miami · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess a novel approach to immunosuppression in allogenic pancreatic islet cell transplant recipients. In addition, the study aims to assess remote site islet processing with culture for pancreatic islet cell transplantation in human subjects.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Islet cell transplantation | Cell therapy | — | Other |